ESR1 and breast carcinoma: Crosstalk between ARs and estrogen receptors (ER) has been reported to modulate both receptors’ activities, with some studies indicating that ARs can inhibit ER-mediated transcriptional activity [65,66,67], while others suggest that ARs may enhance ER signaling in certain breast cancer subtypes [59,68,69].